Skip to main content
Find Faculty / Mark Sirgo

Contact Information:

Mark Sirgo


Dr. Sirgo is currently the CEO of Corium Innovations, a contract development and manufacturing company specializing in prescription and over-the-counter transdermal product delivery. He spent the previous three years as CEO of Aruna Bio, a company specializing in the utilization of neuro exosomes to treat neurodegenerative diseases. Prior to Aruna Bio, he founded and spent 13 years as CEO of the specialty pharmaceutical company BioDelivery Sciences, Inc. (NASDAQ: BDSI), overseeing the development, approval and commercialization of three products for pain and addiction disorder, raising over $600 million in capital through equity and debt financings and growth in market capitalization from $10 million to nearly $1 billion during that period. Dr. Sirgo remained on the Board until the successful sale of the company in 2022. Dr. Sirgo began his career at GSK, where he spent 17 years in roles of increasing responsibility, including Vice President of Clinical Development and Vice President of New Product Marketing. He currently serves on the board of several public and private companies. Dr. Sirgo holds a Doctorate in Pharmacy from Philadelphia College of Pharmacy and Sciences and a Bachelor’s in Pharmacy from The Ohio State University.”

Comments are closed.